Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor PrognosisGail P. Risbridger, Damien Bolton, David Clouston et al.|European Urology|2014Cited by 137
Pre-Invasive Ovarian Mucinous Tumors Are Characterized by <i>CDKN2A</i> and <i>RAS</i> Pathway AberrationsSally M. Hunter|Clinical Cancer Research|2012Cited by 68
Supplementary Tables 1 - 5 from Pre-Invasive Ovarian Mucinous Tumors Are Characterized by <i>CDKN2A</i> and <i>RAS</i> Pathway AberrationsSally M. Hunter, Ian G. Campbell|Unknown|2023Cited by 0